Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (656)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
299
12.350
 Why?
Ovarian Neoplasms
38
2025
455
2.860
 Why?
Papillomavirus Infections
19
2025
170
2.810
 Why?
Endometrial Neoplasms
34
2019
144
2.280
 Why?
Uterine Cervical Dysplasia
16
2017
51
2.270
 Why?
Carcinoma, Squamous Cell
31
2018
331
1.920
 Why?
Gene Expression Regulation, Neoplastic
19
2025
853
1.830
 Why?
Human papillomavirus 16
8
2019
44
1.630
 Why?
Papillomaviridae
17
2025
102
1.530
 Why?
Female
193
2026
28277
1.520
 Why?
Gene Expression Profiling
9
2021
1099
1.440
 Why?
Antineoplastic Combined Chemotherapy Protocols
18
2025
1020
1.400
 Why?
DNA Methylation
22
2025
573
1.280
 Why?
Genital Neoplasms, Female
10
2018
48
1.130
 Why?
Humans
196
2026
52441
1.120
 Why?
Human papillomavirus 18
5
2019
9
1.110
 Why?
Genetic Predisposition to Disease
14
2024
525
1.060
 Why?
Adult
92
2024
14205
1.030
 Why?
Neoplasm Staging
41
2019
768
0.980
 Why?
Middle Aged
99
2024
13133
0.970
 Why?
Adenocarcinoma
18
2018
403
0.950
 Why?
Polymorphism, Single Nucleotide
10
2019
506
0.910
 Why?
Fluorodeoxyglucose F18
15
2022
181
0.910
 Why?
DNA-Binding Proteins
9
2021
423
0.900
 Why?
Neoplasm Recurrence, Local
19
2024
639
0.880
 Why?
MicroRNAs
7
2019
392
0.880
 Why?
Carcinoma
12
2010
135
0.860
 Why?
Genomics
5
2026
266
0.810
 Why?
Oncogene Proteins, Viral
4
2019
52
0.800
 Why?
Radiopharmaceuticals
14
2022
198
0.760
 Why?
Repressor Proteins
4
2019
150
0.760
 Why?
Cervix Uteri
7
2017
49
0.750
 Why?
Cell Line, Tumor
19
2025
1429
0.740
 Why?
Alphapapillomavirus
1
2021
13
0.710
 Why?
DNA, Viral
6
2019
134
0.700
 Why?
Granulosa Cell Tumor
3
2025
4
0.680
 Why?
Immunologic Factors
2
2014
114
0.670
 Why?
Neoplasm Invasiveness
15
2020
278
0.650
 Why?
Neoplasms
8
2022
1314
0.640
 Why?
Genetic Markers
8
2017
108
0.630
 Why?
Genes, Tumor Suppressor
8
2007
73
0.630
 Why?
Neoplasm Proteins
10
2019
328
0.620
 Why?
Aged
70
2024
10242
0.620
 Why?
Immunoglobulins
3
2017
76
0.620
 Why?
Gene Silencing
5
2018
122
0.580
 Why?
Biomedical Research
1
2022
260
0.580
 Why?
Vascular Endothelial Growth Factor A
2
2017
186
0.520
 Why?
Cisplatin
7
2022
282
0.520
 Why?
Proteomics
1
2019
332
0.510
 Why?
Promoter Regions, Genetic
12
2020
465
0.500
 Why?
Aged, 80 and over
36
2024
3449
0.490
 Why?
HLA-C Antigens
2
2018
5
0.490
 Why?
Receptors, KIR
2
2018
11
0.490
 Why?
Positron-Emission Tomography
11
2013
297
0.470
 Why?
Lymph Nodes
10
2010
253
0.470
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.470
 Why?
Tumor Virus Infections
4
2006
47
0.470
 Why?
Microsatellite Repeats
14
2007
42
0.460
 Why?
Alleles
6
2025
279
0.460
 Why?
Disease-Free Survival
17
2013
461
0.460
 Why?
Hysterectomy
15
2022
90
0.460
 Why?
Gynecologic Surgical Procedures
4
2010
30
0.450
 Why?
Virus Integration
3
2025
10
0.440
 Why?
Phenotype
5
2016
792
0.430
 Why?
Prognosis
19
2021
2100
0.420
 Why?
Lymphatic Metastasis
14
2019
210
0.420
 Why?
Immunohistochemistry
13
2024
977
0.410
 Why?
Chromosomes, Human, Pair 6
4
2007
15
0.410
 Why?
Nuclear Proteins
8
2009
247
0.410
 Why?
Loss of Heterozygosity
10
2007
78
0.400
 Why?
Cell Proliferation
7
2025
1013
0.400
 Why?
Ovary
2
2008
101
0.390
 Why?
Membrane Proteins
3
2005
344
0.380
 Why?
Genotype
9
2018
563
0.370
 Why?
Survival Analysis
14
2021
656
0.370
 Why?
Cell Movement
5
2021
271
0.370
 Why?
STAT3 Transcription Factor
3
2021
89
0.370
 Why?
Ultrasonic Therapy
3
2001
30
0.360
 Why?
Peritoneal Neoplasms
4
2008
66
0.360
 Why?
Carcinoma, Endometrioid
6
2014
38
0.360
 Why?
Genes, p53
2
2010
50
0.360
 Why?
Signal Transduction
8
2021
1724
0.340
 Why?
Risk Factors
13
2019
3971
0.340
 Why?
Uterine Neoplasms
5
2009
57
0.340
 Why?
Mutation
12
2018
1331
0.340
 Why?
Carboplatin
2
2009
55
0.330
 Why?
Antibodies, Monoclonal
5
2021
475
0.330
 Why?
Ascites
2
2008
32
0.330
 Why?
Antineoplastic Agents
9
2014
1216
0.330
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
11
0.330
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
14
0.320
 Why?
Cohort Studies
13
2024
1576
0.320
 Why?
Base Sequence
8
2019
632
0.320
 Why?
Membrane Glycoproteins
2
2009
239
0.320
 Why?
Disease Progression
6
2020
870
0.320
 Why?
GTPase-Activating Proteins
1
2009
24
0.320
 Why?
DNA, Neoplasm
11
2006
146
0.310
 Why?
Matrix Metalloproteinase 9
1
2009
88
0.310
 Why?
Chromosomes, Human, Pair 11
3
2005
56
0.310
 Why?
Neoplasms, Glandular and Epithelial
3
2006
41
0.310
 Why?
Brachytherapy
9
2014
50
0.300
 Why?
Combined Modality Therapy
11
2010
641
0.300
 Why?
Proto-Oncogene Proteins c-myc
2
2021
53
0.300
 Why?
Abdominal Neoplasms
1
2009
16
0.300
 Why?
Genome, Human
3
2025
121
0.300
 Why?
Laser Coagulation
1
2009
26
0.300
 Why?
DNA Repair
11
2007
194
0.300
 Why?
Retrospective Studies
33
2024
6694
0.290
 Why?
Drug Administration Schedule
10
2013
370
0.290
 Why?
Deoxycytidine
4
2006
24
0.290
 Why?
Homeodomain Proteins
2
2006
80
0.290
 Why?
RNA-Binding Proteins
2
2021
133
0.280
 Why?
Germ-Line Mutation
3
2024
62
0.280
 Why?
Laparoscopy
3
2022
180
0.280
 Why?
Microsatellite Instability
5
2019
21
0.280
 Why?
Protozoan Proteins
1
2008
33
0.280
 Why?
Kaplan-Meier Estimate
6
2019
485
0.280
 Why?
Ovariectomy
7
2010
115
0.270
 Why?
Antigens, CD
2
2007
213
0.270
 Why?
Breast Neoplasms
6
2026
1203
0.270
 Why?
Drug Resistance, Neoplasm
6
2016
336
0.270
 Why?
Heart Arrest
1
2009
145
0.260
 Why?
Chromosomes, Human, Pair 3
4
2001
18
0.260
 Why?
Polymerase Chain Reaction
9
2010
458
0.260
 Why?
SOXC Transcription Factors
2
2019
13
0.260
 Why?
Receptors, Estrogen
3
2024
133
0.260
 Why?
Topotecan
5
2013
17
0.250
 Why?
POU Domain Factors
1
2006
1
0.250
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.250
 Why?
Vulvar Neoplasms
5
2002
60
0.250
 Why?
Neoplasm Metastasis
5
2021
235
0.240
 Why?
HeLa Cells
3
2021
243
0.240
 Why?
Genome, Viral
2
2025
79
0.240
 Why?
Registries
6
2010
638
0.240
 Why?
Anemia
3
2020
75
0.240
 Why?
Survival Rate
10
2009
944
0.230
 Why?
Young Adult
7
2018
4346
0.230
 Why?
Antineoplastic Agents, Hormonal
1
2025
56
0.230
 Why?
Vaginal Smears
6
2006
28
0.230
 Why?
Breast
1
2026
86
0.230
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
580
0.220
 Why?
Gene Rearrangement
1
2025
76
0.220
 Why?
Chromosome Aberrations
1
2006
295
0.220
 Why?
HSP70 Heat-Shock Proteins
1
2004
71
0.210
 Why?
Receptors, Androgen
1
2024
48
0.210
 Why?
Receptors, Progesterone
1
2024
68
0.210
 Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.210
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.210
 Why?
Quinazolines
1
2003
32
0.210
 Why?
Oncostatin M
2
2021
5
0.210
 Why?
Antigens, Neoplasm
1
2004
145
0.200
 Why?
Polymorphism, Genetic
5
2018
184
0.200
 Why?
Genome-Wide Association Study
2
2017
184
0.200
 Why?
Small Cell Lung Carcinoma
1
2023
29
0.200
 Why?
Omentum
1
2002
16
0.200
 Why?
Case-Control Studies
7
2019
1202
0.200
 Why?
Chromosome Deletion
3
2000
138
0.190
 Why?
Treatment Outcome
23
2014
5508
0.190
 Why?
Neoadjuvant Therapy
2
2022
124
0.190
 Why?
Linkage Disequilibrium
3
2017
41
0.190
 Why?
Proto-Oncogene Proteins c-akt
2
2014
168
0.190
 Why?
Antibodies, Monoclonal, Humanized
5
2013
230
0.190
 Why?
Genetic Variation
4
2019
226
0.180
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.180
 Why?
CA-125 Antigen
3
2008
16
0.180
 Why?
Base Pair Mismatch
5
2006
21
0.180
 Why?
Tumor Microenvironment
2
2021
257
0.180
 Why?
Suction
1
2001
22
0.180
 Why?
Chemoradiotherapy
1
2022
50
0.180
 Why?
Postoperative Complications
3
2022
1065
0.180
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.180
 Why?
Smoking
1
2005
514
0.180
 Why?
Radiotherapy, Conformal
2
2014
52
0.180
 Why?
Proteins
5
2008
353
0.180
 Why?
Carcinoma in Situ
2
2013
72
0.170
 Why?
Adaptor Proteins, Signal Transducing
8
2007
202
0.170
 Why?
Antimetabolites, Antineoplastic
2
2002
37
0.170
 Why?
Colorectal Neoplasms
3
2002
286
0.170
 Why?
Minority Groups
1
2022
136
0.170
 Why?
Fetofetal Transfusion
1
2020
5
0.170
 Why?
Polycythemia
1
2020
9
0.170
 Why?
Gene Regulatory Networks
2
2019
112
0.170
 Why?
Pregnancy, Twin
1
2020
8
0.170
 Why?
Radiotherapy
3
2010
128
0.170
 Why?
Twins, Monozygotic
1
2020
15
0.170
 Why?
Sarcoma
3
2009
68
0.170
 Why?
Lymph Node Excision
7
2019
133
0.170
 Why?
Genetic Diseases, Inborn
1
2000
25
0.170
 Why?
Patient Satisfaction
2
2006
287
0.160
 Why?
Receptor, erbB-3
1
2020
2
0.160
 Why?
Furin
1
2020
3
0.160
 Why?
HLA-DQ Antigens
1
2000
3
0.160
 Why?
Transcriptome
2
2020
357
0.160
 Why?
Receptor, IGF Type 1
1
2020
21
0.160
 Why?
Phosphoproteins
2
2016
123
0.160
 Why?
Tomography, X-Ray Computed
7
2013
1140
0.160
 Why?
Mice, Nude
4
2021
230
0.160
 Why?
Tumor Cells, Cultured
7
2021
441
0.160
 Why?
Prenatal Diagnosis
1
2020
97
0.160
 Why?
RNA, Neoplasm
3
2007
45
0.160
 Why?
Antibodies, Neoplasm
1
2019
27
0.160
 Why?
Students
1
2022
230
0.160
 Why?
Papillomavirus E7 Proteins
2
2017
30
0.150
 Why?
Adolescent
13
2018
6713
0.150
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.150
 Why?
Reproducibility of Results
2
2022
1223
0.150
 Why?
Placenta
1
2020
147
0.150
 Why?
Follow-Up Studies
13
2019
2294
0.150
 Why?
Indocyanine Green
1
2019
29
0.150
 Why?
Decision Making
1
2001
273
0.140
 Why?
Doxorubicin
4
2009
246
0.140
 Why?
Fallopian Tube Neoplasms
3
2008
15
0.140
 Why?
Salvage Therapy
3
2008
137
0.140
 Why?
Cyclooxygenase 2
2
2017
47
0.140
 Why?
Sequence Analysis, DNA
1
2019
220
0.140
 Why?
Transcription Factors
1
2021
570
0.140
 Why?
HLA-DRB1 Chains
1
2017
5
0.140
 Why?
Metabolic Networks and Pathways
1
2018
89
0.140
 Why?
HLA-B Antigens
1
2017
8
0.140
 Why?
Lung Neoplasms
2
2023
643
0.140
 Why?
DNA Copy Number Variations
1
2018
116
0.140
 Why?
Proto-Oncogene Proteins
5
2004
146
0.130
 Why?
Receptors, Vitronectin
1
1997
1
0.130
 Why?
Tumor Suppressor Proteins
3
2005
127
0.130
 Why?
Carcinoma, Adenosquamous
3
2009
9
0.130
 Why?
DNA Mutational Analysis
9
2005
179
0.130
 Why?
Interleukin-10
1
2017
81
0.130
 Why?
Bayes Theorem
1
2017
122
0.130
 Why?
Animals
11
2021
13485
0.130
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
20
0.130
 Why?
Leukocytes, Mononuclear
1
2017
122
0.130
 Why?
In Situ Hybridization
3
2008
69
0.130
 Why?
Protein Binding
1
2019
673
0.130
 Why?
Adipose Tissue
1
2019
205
0.130
 Why?
Radiotherapy, Intensity-Modulated
2
2009
184
0.130
 Why?
Gene Expression Regulation, Viral
1
2017
49
0.130
 Why?
Risk Assessment
9
2019
1349
0.130
 Why?
Radiotherapy Dosage
8
2014
256
0.130
 Why?
Body Mass Index
3
2010
701
0.130
 Why?
Diagnosis, Differential
4
2024
1028
0.120
 Why?
Radiation Injuries
3
2008
114
0.120
 Why?
ROC Curve
1
2017
249
0.120
 Why?
Taxoids
3
2006
38
0.120
 Why?
Biopsy
5
2006
594
0.120
 Why?
Carrier Proteins
7
2006
312
0.120
 Why?
Cells, Cultured
3
2017
1583
0.120
 Why?
Prospective Studies
10
2019
2433
0.120
 Why?
Estrogens
1
2017
228
0.120
 Why?
Molecular Sequence Data
5
2009
778
0.120
 Why?
Colposcopy
3
2006
17
0.120
 Why?
Mice
7
2021
5899
0.120
 Why?
Wound Healing
2
2018
223
0.120
 Why?
Apoptosis
2
2021
1120
0.120
 Why?
Carcinosarcoma
3
2019
18
0.110
 Why?
Sensitivity and Specificity
4
2006
871
0.110
 Why?
Double-Blind Method
1
2017
726
0.110
 Why?
Dose-Response Relationship, Drug
6
2008
1365
0.110
 Why?
Ultrasonography, Doppler, Color
1
1995
30
0.110
 Why?
Algorithms
1
2019
673
0.110
 Why?
Aneurysm
1
1995
31
0.110
 Why?
DNA Primers
2
2006
204
0.110
 Why?
Platinum Compounds
4
2008
10
0.110
 Why?
Protein Kinase Inhibitors
2
2014
231
0.110
 Why?
Obesity
5
2010
1176
0.110
 Why?
Phosphatidylinositol 3-Kinases
2
2014
147
0.110
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
5
0.110
 Why?
Cyclohexanones
1
2014
4
0.110
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
12
0.110
 Why?
Embolization, Therapeutic
1
1995
93
0.110
 Why?
Transcriptional Activation
2
2019
127
0.100
 Why?
Camptothecin
3
2010
14
0.100
 Why?
TOR Serine-Threonine Kinases
1
2014
83
0.100
 Why?
Genetic Association Studies
1
2014
124
0.100
 Why?
Introns
1
2013
53
0.100
 Why?
Hypercalcemia
1
1993
34
0.100
 Why?
Paclitaxel
4
2007
91
0.100
 Why?
Decision Support Techniques
2
2010
73
0.100
 Why?
Chromosome Mapping
3
2005
149
0.100
 Why?
Cell Transformation, Neoplastic
2
2006
187
0.100
 Why?
Pyridines
1
2014
137
0.100
 Why?
Dermatologic Surgical Procedures
1
1992
35
0.100
 Why?
Brain Neoplasms
1
2016
302
0.090
 Why?
Models, Genetic
1
2012
173
0.090
 Why?
Tomography, Emission-Computed
4
2005
53
0.090
 Why?
Keratinocytes
2
2006
91
0.090
 Why?
Groin
2
2002
16
0.090
 Why?
Laser Therapy
1
1992
74
0.090
 Why?
RNA, Messenger
4
2021
1134
0.090
 Why?
Glucose
1
2014
356
0.090
 Why?
Cystadenocarcinoma, Serous
2
2024
73
0.090
 Why?
Exons
3
2007
101
0.090
 Why?
Magnetic Resonance Imaging
3
2014
1507
0.090
 Why?
Infusions, Intravenous
4
2006
212
0.090
 Why?
Pyrazoles
2
2023
116
0.090
 Why?
Heterozygote
2
2004
89
0.090
 Why?
Models, Statistical
1
2012
230
0.090
 Why?
Condylomata Acuminata
1
1991
4
0.090
 Why?
Epithelium
2
2007
65
0.090
 Why?
Goserelin
1
2010
1
0.090
 Why?
Decision Trees
1
2010
23
0.090
 Why?
Estrogen Antagonists
1
2010
21
0.090
 Why?
Predictive Value of Tests
6
2010
938
0.080
 Why?
Ileal Diseases
1
1990
4
0.080
 Why?
Leiomyoma
1
1990
21
0.080
 Why?
Cell Differentiation
2
2009
667
0.080
 Why?
Epigenesis, Genetic
2
2019
396
0.080
 Why?
Polymorphism, Restriction Fragment Length
1
2010
65
0.080
 Why?
Restriction Mapping
3
2006
33
0.080
 Why?
Colonic Neoplasms
2
2004
163
0.080
 Why?
Gastrointestinal Hemorrhage
1
1990
91
0.080
 Why?
Skin Transplantation
1
1990
43
0.080
 Why?
Down-Regulation
4
2020
348
0.080
 Why?
Age Factors
4
2006
1120
0.080
 Why?
Fluorouracil
2
2006
56
0.080
 Why?
Maximum Tolerated Dose
5
2010
39
0.080
 Why?
Lymphatic Vessels
1
2009
38
0.080
 Why?
Endometrium
3
2019
43
0.080
 Why?
Urinary Bladder Diseases
1
2009
17
0.080
 Why?
Intestinal Diseases
1
2009
25
0.080
 Why?
Embolism, Air
1
2009
8
0.080
 Why?
Lasers, Gas
1
2009
6
0.080
 Why?
Transcription, Genetic
4
2019
375
0.070
 Why?
Vaginal Neoplasms
2
2005
5
0.070
 Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.070
 Why?
Fluorine Radioisotopes
1
2008
25
0.070
 Why?
Primary Ovarian Insufficiency
1
2008
4
0.070
 Why?
Infertility, Female
1
2008
18
0.070
 Why?
Eimeria
1
2008
3
0.070
 Why?
Haplotypes
2
2017
95
0.070
 Why?
Polyethylene Glycols
2
2006
93
0.070
 Why?
Up-Regulation
2
2020
462
0.070
 Why?
Cell Cycle Proteins
1
2009
168
0.070
 Why?
Angiogenesis Inhibitors
2
2006
183
0.070
 Why?
Tumor Burden
2
2021
132
0.070
 Why?
Cricetinae
1
2008
189
0.070
 Why?
Ubiquitin
1
2008
70
0.070
 Why?
Expressed Sequence Tags
1
2007
6
0.070
 Why?
Diagnostic Imaging
1
2009
171
0.070
 Why?
Infusion Pumps
1
1987
12
0.070
 Why?
Fluorescent Antibody Technique
1
2007
110
0.070
 Why?
Microdissection
1
2007
19
0.070
 Why?
Models, Biological
2
2008
735
0.070
 Why?
Precancerous Conditions
2
2005
87
0.070
 Why?
Lasers
1
2007
64
0.070
 Why?
MutS Homolog 2 Protein
5
2007
12
0.070
 Why?
Stromal Cells
1
2007
76
0.070
 Why?
Aorta
3
2005
170
0.070
 Why?
Organ Specificity
2
2018
116
0.070
 Why?
Codon
2
2003
42
0.070
 Why?
Pelvic Floor
1
2007
53
0.070
 Why?
Neutropenia
1
2007
113
0.060
 Why?
Recombinant Proteins
1
2008
490
0.060
 Why?
RNA, Double-Stranded
1
2006
23
0.060
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
18
0.060
 Why?
Tissue Fixation
1
2006
35
0.060
 Why?
Pulmonary Embolism
1
1987
81
0.060
 Why?
Intestinal Perforation
2
2006
24
0.060
 Why?
Head and Neck Neoplasms
2
2016
289
0.060
 Why?
Specimen Handling
1
2006
59
0.060
 Why?
Protein Kinases
1
2006
73
0.060
 Why?
Tosyl Compounds
1
2025
2
0.060
 Why?
Leuprolide
1
2025
3
0.060
 Why?
Aromatase Inhibitors
1
2025
16
0.060
 Why?
Anilides
1
2025
20
0.060
 Why?
Chromosomes, Artificial, Yeast
3
2000
7
0.060
 Why?
Nitriles
1
2025
51
0.060
 Why?
Abdomen
1
2006
71
0.060
 Why?
Endometrial Hyperplasia
2
2002
14
0.060
 Why?
Proportional Hazards Models
4
2010
446
0.060
 Why?
Papillomavirus Vaccines
1
2006
69
0.060
 Why?
Neovascularization, Pathologic
1
2006
158
0.060
 Why?
Recurrence
4
2010
680
0.060
 Why?
Terminal Care
1
2005
37
0.060
 Why?
Probability
4
2007
171
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Chromatin
1
2026
143
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
50
0.060
 Why?
Cell Adhesion Molecules
1
2005
89
0.050
 Why?
Quinolines
1
2004
44
0.050
 Why?
Male
11
2018
26874
0.050
 Why?
High-Throughput Nucleotide Sequencing
1
2026
178
0.050
 Why?
Tumor Suppressor Protein p53
1
2006
224
0.050
 Why?
Amyloid
1
2004
36
0.050
 Why?
Tissue Distribution
1
2004
175
0.050
 Why?
Genes, Viral
1
2003
39
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
234
0.050
 Why?
Lactones
1
2003
25
0.050
 Why?
Abdomen, Acute
1
2003
6
0.050
 Why?
Biopsy, Needle
4
2006
181
0.050
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
56
0.050
 Why?
Thrombospondins
1
2003
10
0.050
 Why?
Pyrimidinones
1
2023
17
0.050
 Why?
RNA, Viral
2
2016
123
0.050
 Why?
Obesity, Morbid
1
2004
86
0.050
 Why?
Clinical Competence
1
2006
405
0.050
 Why?
Neoplasms, Second Primary
1
2004
75
0.050
 Why?
Fibroma
1
2003
40
0.050
 Why?
Radiotherapy, Adjuvant
3
2010
65
0.050
 Why?
Congenital Abnormalities
1
2004
118
0.050
 Why?
Uterine Hemorrhage
1
2002
10
0.050
 Why?
Age of Onset
2
2004
109
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
333
0.050
 Why?
PTEN Phosphohydrolase
2
2019
55
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
DNA, Ribosomal
1
2002
26
0.050
 Why?
Blood Transfusion, Autologous
1
2002
4
0.050
 Why?
Pregnancy
3
2020
2642
0.050
 Why?
Blood Donors
1
2002
21
0.050
 Why?
Genital Diseases, Female
1
2002
18
0.050
 Why?
Acridines
1
2002
4
0.050
 Why?
Medical History Taking
1
2002
46
0.050
 Why?
Medical Records
1
2002
83
0.050
 Why?
Complementary Therapies
1
2002
23
0.050
 Why?
Family Health
1
2002
78
0.050
 Why?
AU Rich Elements
1
2021
2
0.050
 Why?
Postmenopause
1
2002
104
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
 Why?
Cytokine Receptor gp130
1
2021
13
0.050
 Why?
RNA Stability
1
2021
29
0.040
 Why?
3' Untranslated Regions
1
2021
54
0.040
 Why?
Receptors, Transforming Growth Factor beta
1
2001
29
0.040
 Why?
Lymphatic Irradiation
1
2001
1
0.040
 Why?
Blotting, Northern
2
2001
107
0.040
 Why?
Internship and Residency
1
2006
438
0.040
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
25
0.040
 Why?
Diet Records
1
2001
19
0.040
 Why?
Blotting, Southern
3
2002
41
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
218
0.040
 Why?
Catheterization, Central Venous
1
2001
79
0.040
 Why?
Equipment Design
1
2001
287
0.040
 Why?
Phosphoric Monoester Hydrolases
1
2000
23
0.040
 Why?
Blood Vessels
1
2001
73
0.040
 Why?
Uganda
1
2020
38
0.040
 Why?
Logistic Models
2
2017
930
0.040
 Why?
Nutrition Assessment
1
2001
66
0.040
 Why?
Isoenzymes
1
2001
171
0.040
 Why?
Risk Management
1
2000
31
0.040
 Why?
Quality Improvement
1
2022
226
0.040
 Why?
Physical Chromosome Mapping
1
2000
7
0.040
 Why?
Incidence
3
2007
1096
0.040
 Why?
Patient Discharge
1
2022
320
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Dietary Fats
1
2001
134
0.040
 Why?
Interviews as Topic
1
2001
270
0.040
 Why?
Cell Survival
1
2021
598
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
14
0.040
 Why?
DNA Repair Enzymes
1
1999
42
0.040
 Why?
Adenosine Triphosphatases
1
1999
91
0.040
 Why?
Cell Nucleus
1
2019
189
0.040
 Why?
Regression Analysis
3
2006
400
0.040
 Why?
Cross-Sectional Studies
1
2024
1677
0.040
 Why?
Coloring Agents
1
2019
68
0.040
 Why?
Molecular Targeted Therapy
1
2019
135
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Pregnancy Outcome
1
2020
255
0.040
 Why?
Gene Dosage
1
2018
73
0.040
 Why?
Histone Demethylases
1
2018
18
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Leptin
1
2019
148
0.030
 Why?
Databases, Genetic
1
2018
82
0.030
 Why?
Estradiol
1
2019
226
0.030
 Why?
Major Histocompatibility Complex
1
2017
13
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2018
56
0.030
 Why?
Genotyping Techniques
1
2017
19
0.030
 Why?
Mass Screening
1
2000
354
0.030
 Why?
Chemokines
1
2017
77
0.030
 Why?
Child
4
2018
7194
0.030
 Why?
Time Factors
4
2010
2987
0.030
 Why?
Receptors, Collagen
1
1997
3
0.030
 Why?
Receptors, Fibronectin
1
1997
5
0.030
 Why?
Interferon-gamma
1
2018
169
0.030
 Why?
Coculture Techniques
1
2017
142
0.030
 Why?
Transforming Growth Factor beta
1
2018
136
0.030
 Why?
Integrins
1
1997
31
0.030
 Why?
Chemotherapy, Adjuvant
2
2010
122
0.030
 Why?
Diet, High-Fat
1
2019
230
0.030
 Why?
Quality-Adjusted Life Years
2
2010
67
0.030
 Why?
Epithelial Cells
2
2006
217
0.030
 Why?
Hepatitis Viruses
1
2016
2
0.030
 Why?
Longitudinal Studies
1
2019
756
0.030
 Why?
Herpesviridae
1
2016
19
0.030
 Why?
Host-Pathogen Interactions
1
2017
130
0.030
 Why?
Viruses
1
2016
24
0.030
 Why?
Mice, Transgenic
1
2017
566
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
41
0.030
 Why?
Pilot Projects
3
2004
725
0.030
 Why?
DNA Replication
1
1997
159
0.030
 Why?
Cost-Benefit Analysis
2
2010
271
0.030
 Why?
Baths
1
1995
5
0.030
 Why?
Plasmids
2
2001
162
0.030
 Why?
Sequence Analysis, RNA
1
2016
96
0.030
 Why?
Central Nervous System Neoplasms
1
2016
69
0.030
 Why?
Fibroblasts
1
2017
357
0.030
 Why?
Macrophages
1
2018
357
0.030
 Why?
Electrosurgery
1
1995
9
0.030
 Why?
Prostatic Neoplasms
1
1998
398
0.030
 Why?
CpG Islands
2
2008
111
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
Computational Biology
1
2016
209
0.030
 Why?
Arteries
1
1995
93
0.030
 Why?
Cytokines
1
2017
622
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
 Why?
Multivariate Analysis
2
2009
601
0.030
 Why?
Treatment Failure
2
2008
117
0.030
 Why?
Missouri
2
2006
66
0.030
 Why?
Organs at Risk
1
2014
75
0.030
 Why?
Inclusion Bodies
1
1993
17
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
20
0.030
 Why?
Cell Division
2
1994
288
0.030
 Why?
Cell Death
1
2014
169
0.030
 Why?
Dementia
1
1995
168
0.030
 Why?
Cholera Toxin
1
1993
15
0.030
 Why?
Cholera
1
1993
2
0.030
 Why?
Imaging, Three-Dimensional
1
2014
150
0.030
 Why?
Risk
2
2004
315
0.020
 Why?
Skin Physiological Phenomena
1
1992
16
0.020
 Why?
Guinea Pigs
1
1992
76
0.020
 Why?
Pelvis
2
2004
65
0.020
 Why?
Epidermis
1
1992
32
0.020
 Why?
Pedigree
2
2004
126
0.020
 Why?
Deoxyglucose
1
2012
35
0.020
 Why?
Regeneration
1
1992
79
0.020
 Why?
Colectomy
1
1992
35
0.020
 Why?
Computer Simulation
1
2012
285
0.020
 Why?
Sequence Deletion
2
2003
69
0.020
 Why?
Amino Acid Sequence
2
2003
576
0.020
 Why?
Premenopause
1
2010
28
0.020
 Why?
Staurosporine
1
2010
10
0.020
 Why?
Anastomosis, Surgical
1
1990
69
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
67
0.020
 Why?
Remission Induction
1
2010
218
0.020
 Why?
Molecular Weight
1
1990
78
0.020
 Why?
ras Proteins
2
2001
62
0.020
 Why?
Cicatrix
1
1990
42
0.020
 Why?
Staining and Labeling
1
1990
92
0.020
 Why?
Hemoglobins
1
1990
114
0.020
 Why?
Chi-Square Distribution
1
2010
292
0.020
 Why?
Perioperative Care
1
2009
43
0.020
 Why?
Fetus
1
1990
191
0.020
 Why?
Urinary Incontinence
1
2009
40
0.020
 Why?
Gene Knockdown Techniques
1
2009
110
0.020
 Why?
Organoplatinum Compounds
1
2008
14
0.020
 Why?
Vinblastine
1
2008
22
0.020
 Why?
Life Style
1
2009
148
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
185
0.020
 Why?
Emotions
1
2009
172
0.020
 Why?
Cadherins
1
2007
61
0.020
 Why?
Cell Line
1
1990
1020
0.020
 Why?
Demography
1
2007
92
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
141
0.020
 Why?
Skin
1
1990
416
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
DNA Mismatch Repair
1
2006
18
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
17
0.020
 Why?
Waxes
1
2006
2
0.020
 Why?
NIH 3T3 Cells
1
2006
52
0.020
 Why?
Immunoenzyme Techniques
2
2001
134
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
11
0.020
 Why?
Chromosomal Instability
1
2006
16
0.020
 Why?
Neoplasm, Residual
1
2007
169
0.020
 Why?
Analysis of Variance
1
2007
558
0.020
 Why?
Cryopreservation
1
2006
41
0.020
 Why?
Transfection
1
2006
365
0.020
 Why?
Gene Expression
1
2008
618
0.020
 Why?
Mutation, Missense
1
2006
108
0.020
 Why?
Nurse Practitioners
1
2006
42
0.010
 Why?
Early Diagnosis
1
2006
84
0.010
 Why?
Gynecology
1
2006
52
0.010
 Why?
Medical Futility
1
2005
8
0.010
 Why?
Ovarian Cysts
1
2005
3
0.010
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.010
 Why?
Cyclophosphamide
1
2006
176
0.010
 Why?
Triage
1
2006
66
0.010
 Why?
Leiomyosarcoma
1
2005
22
0.010
 Why?
Hospice Care
1
2005
17
0.010
 Why?
Cytodiagnosis
1
2005
42
0.010
 Why?
Health Services
1
2005
66
0.010
 Why?
Phosphorylation
1
2006
536
0.010
 Why?
Obstetrics
1
2006
89
0.010
 Why?
Lymphatic System
1
2004
13
0.010
 Why?
Penetrance
1
2004
7
0.010
 Why?
Microscopy, Electron, Transmission
1
2004
68
0.010
 Why?
Area Under Curve
1
2004
182
0.010
 Why?
Calcification, Physiologic
1
2004
42
0.010
 Why?
Ethanol
1
2006
334
0.010
 Why?
Laparotomy
1
2004
36
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Macrolides
1
2003
17
0.010
 Why?
Genomic Instability
1
2004
87
0.010
 Why?
Thrombospondin 1
1
2003
9
0.010
 Why?
Tamoxifen
1
2004
60
0.010
 Why?
Genes, p16
1
2003
9
0.010
 Why?
Codon, Terminator
1
2003
8
0.010
 Why?
Confidence Intervals
1
2003
158
0.010
 Why?
Palliative Care
1
2005
194
0.010
 Why?
Frameshift Mutation
1
2003
18
0.010
 Why?
Administration, Oral
1
2004
455
0.010
 Why?
Liposomes
1
2003
53
0.010
 Why?
Mutagenesis, Insertional
1
2003
24
0.010
 Why?
Body Weight
1
2005
524
0.010
 Why?
Cytoskeletal Proteins
1
2003
47
0.010
 Why?
Physicians
1
2006
237
0.010
 Why?
DNA Transposable Elements
1
2003
107
0.010
 Why?
Prevalence
1
2006
1016
0.010
 Why?
Reference Values
1
2003
316
0.010
 Why?
beta Catenin
1
2003
105
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
Retinoblastoma Protein
1
2002
17
0.010
 Why?
Ifosfamide
1
2002
8
0.010
 Why?
Documentation
1
2002
33
0.010
 Why?
Trans-Activators
1
2003
137
0.010
 Why?
Bleomycin
1
2002
36
0.010
 Why?
Hospitals, University
1
2002
73
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
78
0.010
 Why?
Equipment Failure
1
2001
63
0.010
 Why?
Age Distribution
1
2002
176
0.010
 Why?
Statistics, Nonparametric
1
2002
199
0.010
 Why?
Nucleic Acid Hybridization
2
1991
54
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
83
0.010
 Why?
Carcinoma, Small Cell
1
2001
26
0.010
 Why?
Radiography
1
2002
469
0.010
 Why?
Genes, erbB-1
1
2001
9
0.010
 Why?
Outpatients
1
2002
128
0.010
 Why?
Hospitalization
1
2005
731
0.010
 Why?
DNA
1
2004
544
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
86
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
152
0.010
 Why?
Genetic Linkage
1
2000
26
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
 Why?
Morbidity
1
2000
137
0.010
 Why?
Blotting, Western
1
2001
587
0.010
 Why?
Gene Deletion
1
2000
279
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
177
0.010
 Why?
Chromosomes, Bacterial
1
1998
5
0.010
 Why?
Cloning, Molecular
1
1998
181
0.010
 Why?
Infant
1
2006
3709
0.010
 Why?
Child, Preschool
1
2006
4046
0.010
 Why?
Drug Resistance, Multiple
1
1997
25
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
71
0.010
 Why?
Gene Frequency
1
1997
97
0.010
 Why?
United States
1
2007
5215
0.010
 Why?
Hygiene
1
1995
11
0.010
 Why?
Guidelines as Topic
1
1995
111
0.010
 Why?
Dimethyl Sulfoxide
1
1994
12
0.010
 Why?
Glycerol
1
1994
19
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
52
0.010
 Why?
Drug Carriers
1
1994
68
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
135
0.010
 Why?
Cell Cycle
1
1994
236
0.010
 Why?
H-2 Antigens
1
1993
3
0.010
 Why?
Caregivers
1
1995
239
0.010
 Why?
Cell Line, Transformed
1
1993
74
0.010
 Why?
Mice, Inbred Strains
1
1993
165
0.010
 Why?
Retroperitoneal Space
1
1991
25
0.010
 Why?
Disease Models, Animal
1
1993
1483
0.000
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (656) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department